Intervention Review

Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases

  1. Arturo J Martí-Carvajal1,*,
  2. Despoina-Elvira Karakitsiou2,
  3. Georgia Salanti3

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 14 MAR 2012

Assessed as up-to-date: 27 JAN 2012

DOI: 10.1002/14651858.CD004887.pub3


How to Cite

Martí-Carvajal AJ, Karakitsiou DE, Salanti G. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD004887. DOI: 10.1002/14651858.CD004887.pub3.

Author Information

  1. 1

    Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Edo. Carabobo, Venezuela

  2. 2

    University of Ioannina Medical School, Ioannina, Greece

  3. 3

    University of Ioannina School of Medicine, Department of Hygiene and Epidemiology, Ioannina, Greece

*Arturo J Martí-Carvajal, Universidad de Carabobo and Iberoamerican Cochrane Network, Valencia, Edo. Carabobo, Venezuela. arturo.marti.carvajal@gmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 MAR 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Cho Naing, Kyan Aung, Joon Wah Mak, Reporting ‘number needed to treat’ in meta-analyses: A cross-sectional study, Journal of Evidence-Based Medicine, 2012, 5, 4